User profiles for J. R. Cerhan

James Cerhan

Mayo Clinic
Verified email at mayo.edu
Cited by 64365

Type I and II endometrial cancers: have they different risk factors?

…, LS Cook, C Chen, JR Cerhan… - Journal of Clinical …, 2013 - ascopubs.org
Purpose Endometrial cancers have long been divided into estrogen-dependent type I and
the less common clinically aggressive estrogen-independent type II. Little is known about risk …

Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: systematic review and meta-analysis

A Bardia, IM Tleyjeh, JR Cerhan, AK Sood… - Mayo Clinic …, 2008 - Elsevier
OBJECTIVE To estimate the association between antioxidant use and primary cancer
incidence and mortality and to evaluate these effects across specific antioxidant compounds, …

Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies

…, K Anderson, PA Van Den Brandt, JR Cerhan… - … Biomarkers & Prevention, 2004 - AACR
Intervention trials with supplemental β-carotene have observed either no effect or a harmful
effect on lung cancer risk. Because food composition databases for specific carotenoids …

[HTML][HTML] Body-mass index and mortality among 1.46 million white adults

…, P Hartge, JR Cerhan… - … England Journal of …, 2010 - Mass Medical Soc
Background A high body-mass index (BMI, the weight in kilograms divided by the square of
the height in meters) is associated with increased mortality from cardiovascular disease and …

[HTML][HTML] Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents

…, M Zhou, N Bansal, A Barricarte, B Carter, JR Cerhan… - The Lancet, 2016 - thelancet.com
Background Overweight and obesity are increasing worldwide. To help assess their
relevance to mortality in different populations we conducted individual-participant data meta-…

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

…, AL Feldman, BK Link, AJ Novak, JR Cerhan… - Nature medicine, 2018 - nature.com
Diffuse large B cell lymphoma (DLBCL), the most common lymphoid malignancy in adults,
is a clinically and genetically heterogeneous disease that is further classified into …

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

…, J Westin, BK Link, A Hay, JR Cerhan… - Blood, The Journal …, 2017 - ashpublications.org
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma.
Although 5-year survival rates in the first-line setting range from 60% to 70%, up to 50% …

Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study

…, J Curtis, TR Mikuls, JR Cerhan… - … : Official Journal of …, 2004 - Wiley Online Library
Objective Vitamin D is a potent regulator of calcium homeostasis and may have immunomodulatory
effects. The influence of vitamin D on human autoimmune disease has not been well …

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

…, TM Habermann, JR Cerhan… - Proceedings of the …, 2012 - National Acad Sciences
To gain insight into the genomic basis of diffuse large B-cell lymphoma (DLBCL), we performed
massively parallel whole-exome sequencing of 55 primary tumor samples from patients …

2016 US lymphoid malignancy statistics by World Health Organization subtypes

LR Teras, CE DeSantis, JR Cerhan… - CA: a cancer journal …, 2016 - Wiley Online Library
Collectively, lymphoid neoplasms are the fourth most common cancer and the sixth leading
cause of cancer death in the United States. The authors provide contemporary lymphoid …